Caris Life Sciences

company

About

Caris is a molecular science company that creates and delivers solutions to transform healthcare and improve cancer patient outcomes.

Details

Last Funding Type
Private Equity(PE)
Last Funding Money Raised
$830M
Industries
Biotechnology,Health Care,Health Diagnostics,Medical
Founded date
Jan 1, 1996
Number Of Employee
1001 - 5000
Operating Status
Active
Legal Name
Caris Life Sciences, Inc.
Also Known As
Caris

Caris Molecular Intelligence revolutionizes precision medicine to provide physicians and patients with information about their health. They develop Caris Molecular Intelligence Services which does panomic molecular profiling for oncology.

Caris Life Sciences was founded with a very simple but powerful purpose – to help improve the lives of as many people as possible. Through tireless efforts, breakthrough molecular science, and a passionate commitment to quality, they remain steadfastly focused on the most important part of their work – the patient.

It was founded in 1996 and is based in Irving, Texas.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
$1.29B
Caris Life Sciences has raised a total of $1.29B in funding over 2 rounds. Their latest funding was raised on May 11, 2021 from a Private Equity(PE) round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 11, 2021 Private Equity(PE) $830M 18 Sixth Street Partners Detail
Oct 27, 2020 Debt Financing $75M 1 Sixth Street Partners Detail
Oct 27, 2020 Private Equity(PE) $235M 9 Coatue
Highland Capital Management, LP.
Detail
Oct 1, 2018 Debt Financing $150M 2 Sixth Street Partners Detail

Employee Profiles

Number of Employee Profiles
14
Caris Life Sciences has 14 current employee profiles, including Executive David D. Halbert
Executive
Board member
Executive
Board member
Executive